10-K: Waystar Holding Corp. Reports Fiscal Year 2024 Results

Waystar Holding Corp. files its 10-K report, detailing its financial performance for the year ended December 31, 2024, including revenue of $943.5 million and a net loss of $19.1 million.

Summary

• Waystar Holding Corp. has filed its annual report on Form 10-K for the fiscal year ended December 31, 2024.
• The company's mission is to simplify healthcare payments through its cloud-based software.
• Waystar's platform is used by over 30,000 clients, representing over one million providers.
• In 2024, the company facilitated over six billion healthcare payments transactions, totaling over $1.8 trillion in gross claims volume.
• Total U.S. healthcare spending was $4.9 trillion in 2023 and is expected to reach $7.6 trillion in 2032.
• The company estimates its total addressable market (TAM) was $15 billion in 2022 and has the potential to increase to almost $20 billion in 2027.
• Waystar's Net Revenue Retention Rate for the year ended December 31, 2024, was 110.1%.
• The company had an 83% win rate against competitors from 2022 through 2024 in situations where the client ultimately elected to switch vendors or purchase a new solution.
• Revenue for the year ended December 31, 2024, was $943.5 million, a 19.3% increase from the previous year.
• The net loss for 2024 was $19.1 million, compared to a net loss of $51.3 million in 2023.
• Adjusted EBITDA for 2024 was $383.5 million, a 14.9% increase from 2023.
• The company completed an IPO in June 2024, raising $914.3 million after underwriting discounts and commissions.
• As of December 31, 2024, the company had outstanding indebtedness of approximately $1.2 billion.
• The company is subject to extensive and complex federal and state laws and regulations regarding healthcare and data privacy.
• The company is an emerging growth company and has taken advantage of certain exemptions and reduced disclosure requirements.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong revenue growth and improved profitability, but also acknowledges risks and challenges inherent in the industry and the company's operations.

Positives

• Significant revenue growth of 19.3% year-over-year, reaching $943.5 million in 2024.
• Strong Net Revenue Retention Rate of 110.1%, indicating high client satisfaction and loyalty.
• Adjusted EBITDA increased by 14.9%, demonstrating improved profitability.
• Large client base of over 30,000, representing over one million providers.
• High win rate against competitors, indicating a strong competitive position.
• Successful completion of an IPO, raising significant capital for future growth.
• The company's TAM has the potential to increase to almost $20 billion in 2027.

Negatives

• The company reported a net loss of $19.1 million for 2024, although this is an improvement from the $51.3 million loss in 2023.
• The company operates in a highly competitive industry.
• The company has a substantial amount of debt, which could adversely affect its financial position.

Risks

• The company operates in a highly competitive industry with rapidly evolving technology and regulatory requirements.
• The company's ability to retain existing clients and attract new clients is critical to its success.
• The company's growth relies on the growth and success of its clients and overall healthcare transaction volumes, which are subject to factors outside of its control.
• Consolidation in the healthcare industry could adversely impact the company's business.
• The company faces a selling cycle of variable length to secure new client agreements.
• The company depends on its senior management team and must continue to attract and retain highly skilled employees.
• The estimates and assumptions used to determine the size of the company's total addressable market may prove to be inaccurate.
• The company may not be able to develop and market new solutions or enhance existing solutions to respond to technological changes or evolving industry standards.
• The company's business depends on the interoperability, connectivity, and integration of its solutions with its clients and their vendors' networks and infrastructures.
• The successful operation of the company's business depends upon the performance and reliability of internet, mobile, and other infrastructure, none of which are under its control.
• The company's business would be adversely affected if it cannot obtain, process, use, disclose, or distribute the highly regulated data it requires to provide its solutions.
• The company relies on certain third-party vendors and providers.
• Any errors or malfunctions in the company's products and solutions could result in liability to its clients.
• Failure by the company's clients to obtain proper permissions or provide it with accurate and appropriate information may result in claims against it or may limit or prevent its use of information.
• Certain of the company's solutions present the potential for embezzlement, identity theft, or other similar illegal behavior by its employees or vendors, and a failure of its employees or vendors to observe quality standards or adhere to environmental, social, and governance standards could damage its reputation.
• The company must comply with the applicable rules of the National Automated Clearing House Association (NACHA), and it, its clients, and its sales partners must comply with the applicable requirements of card networks.
• The company is subject to increases in card network fees and other changes to fee arrangements.
• The company is subject to the effect of payer and provider conduct which it cannot control.
• Privacy concerns or security breaches or incidents relating to the company's platform could result in economic loss, damage to its reputation, deter users from using its products, expose it to legal penalties and liability, and otherwise adversely affect its business.
• The company's business is subject to complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity.
• If the company's intellectual property rights are not adequately protected and enforced, it may not be able to build name recognition or protect its technology and products.
• The company's business depends on its ability to use or license data and integrate third-party technologies.
• The company's use of open source software could adversely affect its ability to offer its products and solutions and subject it to possible litigation.
• Third parties may initiate legal proceedings alleging that the company is infringing or otherwise violating their intellectual property rights.
• The company may be subject to claims that its employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties.
• The company conducts business in a heavily regulated industry.
• The healthcare regulatory and political framework is uncertain and evolving.
• The company is subject to health care laws and data privacy and security laws and regulations governing its Processing of personal information, including PHI, personal health records, and payment card data.
• The company may experience reduced revenues and/or be forced to reduce its prices in response to changes to the healthcare regulatory landscape.
• The company may be a party to legal, regulatory, and other proceedings that could result in adverse outcomes.
• The company is contractually required to comply with Bank Secrecy Act and Anti-Money Laundering (BSA/AML) laws and regulations as a payment facilitator in certain instances.
• Existing laws regulate the company's ability to engage in certain marketing activities.
• The company must comply fully with website accessibility standards.
• The company could be subject to changes in its tax rates, the adoption of new tax legislation or exposure to additional tax liabilities.
• The company's ability to use its net operating losses (NOLs) to offset future taxable income may be subject to certain limitations.
• Goodwill and other intangible assets, net represent approximately 89% of the company's total assets as of December 31, 2024 and it could suffer losses due to asset impairment charges.
• The company has a substantial amount of debt, which could adversely affect its financial position and its ability to raise additional capital and prevent it from fulfilling its obligations under its obligations.
• Restrictive covenants in the agreements governing the company's Credit Facilities may restrict its ability to pursue its business strategies.
• Interest rate fluctuations may affect the company's results of operations and financial condition.
• In order to support the growth of its business, the company may need to incur additional indebtedness under its current Credit Facilities or seek capital through new equity or debt financings, which sources of additional capital may not be available to it on acceptable terms or at all.
• The company's business is significantly impacted by general macroeconomic conditions.
• The company has a history of losses and it may not achieve or maintain profitability in the future.
• The Institutional Investors hold a significant percentage of the company's outstanding common stock and their interests may be different than the interests of other holders of its securities.
• The company is an emerging growth company and it cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make its common stock less attractive to investors.
• The company has incurred significant increased costs and become subject to additional regulations and requirements as a result of becoming a public company, and its management is required to devote substantial time to compliance matters.
• Failure to comply with requirements to design, implement, and maintain effective internal controls could have a material adverse effect on the company's business and stock price.
• The market price of the company's common stock has been volatile and may continue to fluctuate substantially, which could result in substantial losses for purchasers of its common stock.
• Future issuances of the company's common stock may dilute the percentage ownership of existing owners, which could reduce their influence over matters on which stockholders vote.
• Because the company has no current plans to pay cash dividends on its common stock, stockholders may not receive any return on investment unless they sell their shares of common stock for a price greater than that which they paid for it.
• Future sales, or the perception of future sales, by the company or its existing stockholders in the public market could cause the market price for its common stock to decline.
• If securities analysts do not publish research or reports about the company's business or if they downgrade its stock or its sector, its stock price and trading volume could decline.
• Anti-takeover provisions in the company's organizational documents could delay or prevent a change of control.
• The company's board of directors is authorized to issue and designate shares of its preferred stock in additional series without stockholder approval.
• The company's amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware (or if such court does not have jurisdiction, another state or the federal courts (as appropriate) located within the State of Delaware) will be the sole and exclusive forum for certain stockholder litigation matters, which could limit its stockholders ability to obtain a favorable judicial forum for disputes with it or its directors, officers, employees, or stockholders.

Future Outlook

The company expects to continue to grow its market share by virtue of its differentiated platform and capabilities and plans to capitalize on its market opportunity by executing on its growth strategies.

Industry Context

The healthcare industry is one of the largest and most complex vertical end-markets within the U.S. economy, accounting for 17.6% of the U.S. gross domestic product as of 2023. National health expenditures are expected to grow 5.6% annually reaching $7.6 trillion in 2032, or 19.7% of GDP.

Comparison to Industry Standards

• The market share of Waystar's solutions within the hospital segment is approximately 4% and within the ambulatory practice segment is approximately 8% (calculated as a percentage of revenue as compared to TAM estimates by setting of care).
• This demonstrates the ample white space in which Waystar can continue driving its growth.
• The company's Net Revenue Retention Rate of 110.1% for the year ended December 31, 2024, indicates strong client loyalty and is a key performance indicator compared to industry benchmarks.

Related Party Transactions

• The company had $35.6 million of outstanding debt as part of the first lien term loan facility from Bain Affiliated Funds and CPPIB Credit Investments III Inc., affiliates of Bain Capital LP and Canada Pension Plan Investment Board.
• Canada Pension Plan Investment Board has an ownership interest in the company and a significant interest in the landlord that leases the company office space under an operating lease agreement in Houston, Texas.
• Bain Capital LP has an ownership interest in the company and a significant interest in some clients for whom the company provides software solutions.
• Rocket Software and Fidelity Information Services are vendors that provide the company with software solutions, and Bain beneficially owns greater than 10% of each of these companies.

Stakeholder Impact

• Shareholders: The company's financial performance and strategic initiatives will impact shareholder value.
• Employees: The company's compensation and benefits policies, as well as its commitment to inclusion and diversity, will impact employees.
• Customers: The company's ability to provide innovative and reliable solutions will impact its customers' ability to simplify healthcare payments.
• Suppliers: The company's relationships with third-party vendors and providers will impact its ability to deliver its solutions.
• Creditors: The company's ability to meet its debt service obligations will impact its creditors.

Next Steps

• The company plans to continue driving growth within its current client base.
• The company plans to grow its client base.
• The company plans to deepen and expand its relationships with strategic channel partners.
• The company plans to innovate and develop adjacent solutions.
• The company plans to selectively pursue strategic acquisitions.

Key Dates

Keywords

healthcare payments, cloud software, revenue cycle management, financial performance, 10-K, Waystar, EBITDA, HIPAA, AI, SaaS